Copyright
©The Author(s) 2016.
World J Hepatol. Jan 8, 2016; 8(1): 36-57
Published online Jan 8, 2016. doi: 10.4254/wjh.v8.i1.36
Published online Jan 8, 2016. doi: 10.4254/wjh.v8.i1.36
Summary of the clinical characteristics about PVS |
The true incidence of PVS is not really known, but is thought to be < 3% |
The major complication of PVS is the evolution to PVT if not treated |
The majority of patients with PVS are asymptomatic and the diagnosis of stenosis is an incidental finding detected on routine DUS screening |
Risk factors of PVS are almost exclusively represented by technical errors, particularly if a tapered anastomosis is required in the case of a vessel size mismatch between donor and recipient |
Pre-OLT radiotherapy is another major predisposing factor of PVS |
DUS with the finding of a stenosis ratio > 50% or a portal velocity ratio > 3:1 defines PVS. Contrast-enhanced CT and portography are used to confirm the diagnosis |
If PVS is asymptomatic, no therapeutic intervention with close surveillance is possible, but anticoagulation therapy is recommended |
In patients with clinical manifestations, percutaneous radiological intervention is the method of choice by transhepatic or transjugular access to perform angioplasty with our without stent placement; this prevents recurrence with a high rate of success and low rate of complications |
- Citation: Piardi T, Lhuaire M, Bruno O, Memeo R, Pessaux P, Kianmanesh R, Sommacale D. Vascular complications following liver transplantation: A literature review of advances in 2015. World J Hepatol 2016; 8(1): 36-57
- URL: https://www.wjgnet.com/1948-5182/full/v8/i1/36.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i1.36